All Cancer Microbiology articles – Page 3
-
NewsWorld’s first oral microbiome-based nanomedicine to supercharge anti-cancer immunity
Researchers have successfully developed the world’s first oral, microbiome-based nanomedicine which enhances the ability of immune cells to attack cancer cells.
-
NewsTumor-like tissue environments could hold clues to curing HIV
The tissue microenvironments surrounding HIV-infected immune cells look a lot like those surrounding cancerous tumors, reports a new study. The findings help explain why HIV has been so difficult to cure.
-
NewsThe ‘windows’ that set genotoxic bacteria on a track towards colorectal cancer
Scientists have identified potential ‘windows of opportunity’ that can provide routes for some pathogenic strains of E coli to cause mutations that ultimately lead to colorectal cancers.
-
NewsHidden microbial ecosystems inside tumors reveal new frontiers for cancer treatment
Far from being sterile, tumors host complex communities of bacteria, fungi, and viruses that actively influence disease progression, immune responses, and treatment outcomes. A review highlights how these microbial populations function as key regulators of tumor immunity.
-
NewsIntratumoral Fusobacterium as a prognostic and predictive biomarker in resectable colorectal cancer
Research supports the use of Fusobacterium as a prognostic and predictive biomarker in patients with resectable stage I–III CRC. Its presence was associated with more aggressive disease, a weaker immune response, and limited benefit from adjuvant chemotherapy.
-
NewsReshaping the gut microbiome can boost chemotherapy delivery to tumors
A common antibiotic reshaped gut bacteria in preclinical models, significantly reducing liver clearance and doubling how long chemotherapy remained in circulation to reach tumors.
-
NewsThe amino acid arginine helps the body fight tumors and viral infections
Scientists have discovered that an arginine-deficient diet impacts the immune system by stalling the production of the MHC-1 protein, which alerts the immune system to dangers such as a mutating cell or an invading virus.
-
NewsBugs as drugs: Engineered gut bacteria show promise against pancreatic cancer
Cancer immunotherapies have transformed treatment for many cancers, but pancreatic cancer remains especially difficult to treat. One major reason is that pancreatic tumors often create a “cold” tumor microenvironment, where the tumor prevents immune cells from mounting a strong attack. In a new study published in Science ...
-
NewsResearchers link gut microbe to cancer-fighting immune response
A new study is the first to show metabolites produced by certain bacteria in the gut can positively impact the body’s immune response to cancer.
-
NewsGenetically engineered Bifidobacterium shows potential for oral delivery of cancer vaccines
A novel oral vaccine platform using genetically engineered Bifidobacterium could enhance anti-tumor immunity. In an exploratory phase I clinical study, the vaccine was well tolerated and generated immunologic and clinical findings that warrant further investigation.
-
NewsMicrobiome and cancer: From passive bystanders to active players
A special issue reviews how microbiome science and cancer biology can converge as an integrated front for precision oncology. Articles span topics from hepatocellular carcinoma and colorectal cancer to gastric cancer and pancreatic ductal adenocarcinoma.
-
NewsResearchers call for increased screening for parasitic disease linked to HIV and cervical cancer risk
New research has highlighted the need to test millions of women and girls for female genital schistosomiasis (FGS), a neglected disease that can increase the risk of chronic illness, HIV and cervical cancer.
-
NewsGene-editing tool can unearth new cancer treatments from fungi
Engineers have developed a gene-editing tool built specifically for fungi, unlocking a hidden library of molecules—including some with early anti-cancer promise—from one of biology’s most overlooked kingdoms.
-
NewsThe respiratory microbiota in lung cancer: from dysbiosis and immunomodulatory networks to therapeutic opportunities
A comprehensive review reveals that dysbiosis of the respiratory microbiota drives lung cancer through four integrated pathways: oncogenic signaling, epigenetic/metabolic reprogramming, and chronic immune dysregulation.
-
NewsCommon probiotic ingredient turns immune cells into tumor killers
A probiotic bacterium secretes mannose—that significantly suppresses melanoma growth in mice by activating the body’s own immune defenses. Mannose enters CD8⁺ T cells through glucose transporters and inhibits a key protein called YAP1, which normally restrains T-cell killing power.
-
NewsKRICT discovers novel SRV2 envelope protein for efficient car immune cell production
Researchers identify a novel SRV2 envelope protein that serves as a key to unlock immune cells, enabling more efficient delivery of anticancer genes and improving the production and therapeutic performance of CAR immune cells.
-
NewsGut microbiome: The hidden architect of liver cancer immunotherapy response
A comprehensive review synthesizes current advances linking gut bacteria to immunotherapy outcomes in hepatocellular carcinoma (HCC), the most common type of primary liver cancer.
-
NewsReview unmasks hidden role of gut microbes in colorectal cancer
A new review systematically dissects how the gut microbiota and host cells talk to each other across four molecular layers – genome, transcriptome, epigenome, and metabolome – and highlights the computational innovations that make such multi‑omics integration possible.
-
NewsEnvironmental fungi found to alter vaginal mycobiome and cervical disease progression during dysbiosis
Scientists have demonstrated for the first time that environmental fungi actively interact with the vaginal bacteriome and mycobiome with likely implications for cervical disease progression.
-
NewsMicrobes rewrite the rules of cancer immunotherapy by triggering immunogenic cell death
A new study reveals that microbiota and their metabolites can effectively reprogram immunogenic cell death (ICD), a unique form of cell death that activates the body‘s immune system against tumors, transforming immunologically “cold” therapy-resistant tumors into “hot” responsive ones.